<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND OBJECTIVES: Pregnancies in women with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> are considered high-risk due to high rates of maternal and fetal complications </plain></SENT>
<SENT sid="1" pm="."><plain>However, there has not been a formal analysis addressing the issue of maternal <z:hpo ids='HP_0011420'>deaths</z:hpo> in these women </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to perform a literature review of the maternal <z:hpo ids='HP_0011420'>deaths</z:hpo> in women with SLE and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> to: (1) identify the main causes of <z:hpo ids='HP_0011420'>death</z:hpo> and (2) discuss possible reasons for these causes, and strategies that may improve patient care and outcomes </plain></SENT>
<SENT sid="3" pm="."><plain>DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENT: We performed an extensive electronic literature search from 1962 to 2009 using online databases (PubMed, Embase, Lilacs, Cochrane Controlled Trials Register, Medline, and Science Citation Index) </plain></SENT>
<SENT sid="4" pm="."><plain>Studies were included if they reported pregnancies in patients with SLE and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> with at least one reported maternal <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: We identified 13 studies that reported a total of 17 <z:hpo ids='HP_0011420'>deaths</z:hpo> in the 6 week post-partum period that were attributable to SLE and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> cases, <z:hpo ids='HP_0011420'>death</z:hpo> occurred in the setting of active disease, and was attributed either to <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in 41.2% (n = 7), or disease activity in 29.4% (n = 5) </plain></SENT>
<SENT sid="7" pm="."><plain>The remaining <z:hpo ids='HP_0011420'>deaths</z:hpo> were due to pulmonary <z:mpath ids='MPATH_110'>embolus</z:mpath> in 11.8% (n = 2), pregnancy-associated <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> in 5.9% (n = 1), <z:e sem="disease" ids="C0001623" disease_type="Disease or Syndrome" abbrv="">adrenal failure</z:e> due to abrupt steroid withdrawal in 5.9% (n = 1), and undefined in 5.9% (n = 1) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0000001'>All</z:hpo> maternal <z:hpo ids='HP_0011420'>deaths</z:hpo> in patients with SLE and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> occurred in those with active disease, with disease activity/complications and <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> (mainly opportunistic) being the two major causes </plain></SENT>
<SENT sid="9" pm="."><plain>The presented evidence further supports timing of pregnancy relative to SLE activity, and the judicious use of <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> in pregnant patients </plain></SENT>
</text></document>